https://www.selleckchem.com/products/nsc16168.html
ereas warfarin and rivoraxaban resumption were associated with an increased risk of recurrent GIB.Clostridium difficile infection (CDI) recurs in ∼20% of patients. Prior studies indicated that antibody responses directed against the C. difficile toxins A and B were potentially associated with lower risk of recurrent CDI. Here we tested the hypothesis that circulating anti-toxin IgG antibody levels associate with reduced risk of recurrent CDI. A cohort study with prospective enrollment and retrospective data abstraction examined antibod
Like
Comment
Share
